| Dr Jonelle A Raphael, MD | |
|
208 Mill Rd, Fairhaven, MA 02719-5208 | |
| (508) 973-2224 | |
| (508) 973-0394 |
| Full Name | Dr Jonelle A Raphael |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 19 Years |
| Location | 208 Mill Rd, Fairhaven, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497919245 | NPI | - | NPPES |
| 110099022A | Medicaid | MA | |
| JR97162 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 253492 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southcoast Physicians Group Inc | 0749171957 | 746 |
News Archive
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.
Proteins that play key roles in the timing of cell division also moonlight in regulating blood sugar levels, UT Southwestern Medical Center researchers have found.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks, says a new report by the Institute of Medicine and National Research Council.
› Verified 8 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.
Proteins that play key roles in the timing of cell division also moonlight in regulating blood sugar levels, UT Southwestern Medical Center researchers have found.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks, says a new report by the Institute of Medicine and National Research Council.
› Verified 8 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.
Proteins that play key roles in the timing of cell division also moonlight in regulating blood sugar levels, UT Southwestern Medical Center researchers have found.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks, says a new report by the Institute of Medicine and National Research Council.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonelle A Raphael, MD 200 Mill Rd, Suite 180, Fairhaven, MA 02719-5252 Ph: (508) 973-2000 | Dr Jonelle A Raphael, MD 208 Mill Rd, Fairhaven, MA 02719-5208 Ph: (508) 973-2224 |
News Archive
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.
Proteins that play key roles in the timing of cell division also moonlight in regulating blood sugar levels, UT Southwestern Medical Center researchers have found.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks, says a new report by the Institute of Medicine and National Research Council.
› Verified 8 days ago
Todd F Roberts, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Nicholas Robert Ondrasik, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2224 Fax: 508-973-0394 | |
Dr. Alexis Pappas, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2661 Fax: 508-973-0314 | |
Elizabeth M Blanchard, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Abena A. Addo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-996-1800 Fax: 508-992-7906 | |
Chandra S Reddivari, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 Mill Road, Suite 190, Fairhaven, MA 02719 Phone: 508-973-0857 Fax: 508-973-2176 | |
Nosheen Javed, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2207 Fax: 508-973-2505 |